microdosing glp 1 what is it GLP-1 Medications GLP-1 Microdosing, Brain Health &
Description
is supported by a Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology, a Sinai Health-Novo Nordisk Foundation Chair in Regulatory Peptides, CIHR grants 154321 and 192044, and Diabetes Canada-Canadian Cancer Society grant OG-3- 24-5819-DD
It is a serious complication, particularly in patients who have undergone upper gastrointestinal (GI) tract surgery, such as bariatric and metabolic surgery, because it can have a significant impact on GI physiological functions, recovery, quality of life, and patients health
Fortunately for most GLP-1 users, the gastrointestinal side effects are mild to moderate in severity, generally tolerable and tend to improve with time, especially with careful and slow dose titration
"We just don't know yet." What you should do If you have PAD, you might be wondering if it's time to ask your doctor about taking a GLP-1 drug
JAMA 323(12):11751183
